News - Vyvanse, Intuniv

Filter

Current filters:

VyvanseIntuniv

Popular Filters

Global ADHD market set to grow at a CAGR of 8% to 2018

14-12-2011

The global attention deficit hyperactivity disorder (ADHD) therapeutics market was valued at $3.86 billion…

DaytranaGlobalIntunivMarkets & MarketingNeurologicalPharmaceuticalShireVyvanse

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top